Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy For Heart Failure market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy For Heart Failuremarket, defines the market attractiveness level of Gene Therapy For Heart Failure market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy For Heart Failure industry, describes the types of Gene Therapy For Heart Failure market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy For Heart Failure market and the development prospects and opportunities of Gene Therapy For Heart Failure industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy For Heart Failure market in Chapter 13.
By Player:
Askbio
DINAQOR
Blue Rock
Cardior
Heartseed
PRECIGEN
Uniqure
RENOVACORINC
NOVARTIS
By Type:
Gene Modification
Gene Replacement
Others
By End-User:
Hospital
Laboratory
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy For Heart Failure Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy For Heart Failure Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy For Heart Failure Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy For Heart Failure Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy For Heart Failure Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.2 United States Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.3 Europe Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.4 China Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.5 Japan Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.6 India Gene Therapy For Heart Failure Consumption (2017-2022)
-
7.7 South Korea Gene Therapy For Heart Failure Consumption (2017-2022)
8 Region and Country-wise Gene Therapy For Heart Failure Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy For Heart Failure Consumption Forecast (2022-2028)
9 Global Gene Therapy For Heart Failure Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy For Heart Failure Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gene Modification Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gene Replacement Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy For Heart Failure Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Laboratory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy For Heart Failure Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy For Heart Failure Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gene Modification Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Gene Replacement Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy For Heart Failure Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy For Heart Failure Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy For Heart Failure Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy For Heart Failure Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy For Heart Failure Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy For Heart Failure Market Competitive Analysis
-
14.1 Askbio
-
14.1.1 Askbio Company Details
-
14.1.2 Askbio Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Askbio Gene Therapy For Heart Failure Product and Service
-
14.2 DINAQOR
-
14.2.1 DINAQOR Company Details
-
14.2.2 DINAQOR Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 DINAQOR Gene Therapy For Heart Failure Product and Service
-
14.3 Blue Rock
-
14.3.1 Blue Rock Company Details
-
14.3.2 Blue Rock Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Blue Rock Gene Therapy For Heart Failure Product and Service
-
14.4 Cardior
-
14.4.1 Cardior Company Details
-
14.4.2 Cardior Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cardior Gene Therapy For Heart Failure Product and Service
-
14.5 Heartseed
-
14.5.1 Heartseed Company Details
-
14.5.2 Heartseed Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Heartseed Gene Therapy For Heart Failure Product and Service
-
14.6 PRECIGEN
-
14.6.1 PRECIGEN Company Details
-
14.6.2 PRECIGEN Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 PRECIGEN Gene Therapy For Heart Failure Product and Service
-
14.7 Uniqure
-
14.7.1 Uniqure Company Details
-
14.7.2 Uniqure Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Uniqure Gene Therapy For Heart Failure Product and Service
-
14.8 RENOVACORINC
-
14.8.1 RENOVACORINC Company Details
-
14.8.2 RENOVACORINC Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 RENOVACORINC Gene Therapy For Heart Failure Product and Service
-
14.9 NOVARTIS
-
14.9.1 NOVARTIS Company Details
-
14.9.2 NOVARTIS Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 NOVARTIS Gene Therapy For Heart Failure Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy For Heart Failure
-
Figure Gene Therapy For Heart Failure Picture
-
Table Global Gene Therapy For Heart Failure Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy For Heart Failure Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy For Heart Failure Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy For Heart Failure Consumption by Country (2017-2022)
-
Figure United States Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy For Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy For Heart Failure Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy For Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Modification Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Replacement Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Modification Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Replacement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy For Heart Failure Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy For Heart Failure Export by Region (Top 5 Countries) (2017-2028)
-
Table Askbio (Foundation Year, Company Profile and etc.)
-
Table Askbio Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table Askbio Gene Therapy For Heart Failure Product and Service
-
Table DINAQOR (Foundation Year, Company Profile and etc.)
-
Table DINAQOR Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table DINAQOR Gene Therapy For Heart Failure Product and Service
-
Table Blue Rock (Foundation Year, Company Profile and etc.)
-
Table Blue Rock Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table Blue Rock Gene Therapy For Heart Failure Product and Service
-
Table Cardior (Foundation Year, Company Profile and etc.)
-
Table Cardior Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardior Gene Therapy For Heart Failure Product and Service
-
Table Heartseed (Foundation Year, Company Profile and etc.)
-
Table Heartseed Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heartseed Gene Therapy For Heart Failure Product and Service
-
Table PRECIGEN (Foundation Year, Company Profile and etc.)
-
Table PRECIGEN Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table PRECIGEN Gene Therapy For Heart Failure Product and Service
-
Table Uniqure (Foundation Year, Company Profile and etc.)
-
Table Uniqure Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table Uniqure Gene Therapy For Heart Failure Product and Service
-
Table RENOVACORINC (Foundation Year, Company Profile and etc.)
-
Table RENOVACORINC Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table RENOVACORINC Gene Therapy For Heart Failure Product and Service
-
Table NOVARTIS (Foundation Year, Company Profile and etc.)
-
Table NOVARTIS Gene Therapy For Heart Failure Sales, Price, Value and Gross Profit (2017-2022)
-
Table NOVARTIS Gene Therapy For Heart Failure Product and Service
-
